{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:03:37Z","timestamp":1791407017698,"version":"4.3.3"},"reference-count":18,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T00:00:00Z","timestamp":1448496000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T00:00:00Z","timestamp":1448496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"TerumoBCT, Inc"},{"name":"Joseph M. West Family Memorial Fund"},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Muscle Nerve"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1002\/mus.24960","type":"journal-article","created":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T03:15:30Z","timestamp":1446434130000},"page":"872-876","source":"Crossref","is-referenced-by-count":21,"title":["Cost-minimization analysis comparing intravenous immunoglobulin with plasma exchange in the management of patients with myasthenia gravis"],"prefix":"10.1002","volume":"53","author":[{"given":"Julio C.","family":"Furlan","sequence":"first","affiliation":[{"name":"Department of Medicine; Division of Physical Medicine and Rehabilitation; Lyndhurst Centre; Toronto Rehabilitation Institute; 520 Sutherland Drive, Room 205 Toronto Ontario M4G 3V9 Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Barth","sequence":"additional","affiliation":[{"name":"Department of Medicine; Division of Hematology; University of Toronto; Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Barnett","sequence":"additional","affiliation":[{"name":"Division of Neurology; University Health Network; Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Bril","sequence":"additional","affiliation":[{"name":"Division of Neurology; University Health Network; Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,11,26]]},"reference":[{"key":"10.1002\/mus.24960-BIB0001|mus24960-cit-0001","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.293.15.1906","article-title":"Does this patient have myasthenia gravis?","volume":"293","author":"Scherer","year":"2005","journal-title":"JAMA"},{"key":"10.1002\/mus.24960-BIB0002|mus24960-cit-0002","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis","volume":"357","author":"Vincent","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/mus.24960-BIB0003|mus24960-cit-0003","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1212\/WNL.0b013e31821e5505","article-title":"Comparison of IVIg and PLEX in patients with myasthenia gravis","volume":"76","author":"Barth","year":"2011","journal-title":"Neurology"},{"key":"10.1002\/mus.24960-BIB0004|mus24960-cit-0004","first-page":"2008","volume-title":"Ontario Health Insurance (OHIP) Schedule of benefits and fees","author":"OMHLTC","year":"2008"},{"key":"10.1002\/mus.24960-BIB0005|mus24960-cit-0005","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/mus.22327","article-title":"Estimated cost of treating myasthenia gravis in an insured U.S. population","volume":"45","author":"Guptill","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1002\/mus.24960-BIB0006|mus24960-cit-0006","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000330835","article-title":"The National Trauma Registry as a Canadian spine trauma database: a validation study using an institutional clinical database","volume":"37","author":"Furlan","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1002\/mus.24960-BIB0007|mus24960-cit-0007","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.annepidem.2015.03.008","article-title":"Enrollment factors and bias of disease prevalence estimates in administrative claims data","volume":"25","author":"Jensen","year":"2015","journal-title":"Ann Epidemiol"},{"key":"10.1002\/mus.24960-BIB0008|mus24960-cit-0008","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/1475-6773.12131","article-title":"Insurer market structure and variation in commercial health care spending","volume":"49","author":"McKellar","year":"2014","journal-title":"Health Serv Res"},{"key":"10.1002\/mus.24960-BIB0009|mus24960-cit-0009","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/CND.0b013e31822c34dd","article-title":"Plasma exchange versus intravenous immunoglobulin for myasthenia gravis crisis: an acute hospital cost comparison study","volume":"13","author":"Heatwole","year":"2011","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1002\/mus.24960-BIB0010|mus24960-cit-0010","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ana.22139","article-title":"Comparative analysis of therapeutic options used for myasthenia gravis","volume":"68","author":"Mandawat","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1002\/mus.24960-BIB0011|mus24960-cit-0011","first-page":"41","article-title":"Efficient utilization of medical practice resources: a framework and case analysis","volume":"30","author":"Ghosh","year":"2003","journal-title":"J Health Care Finance"},{"key":"10.1002\/mus.24960-BIB0012|mus24960-cit-0012","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/hec.584","article-title":"The death of cost-minimization analysis?","volume":"10","author":"Briggs","year":"2001","journal-title":"Health Econ"},{"key":"10.1002\/mus.24960-BIB0013|mus24960-cit-0013","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/bmj.307.6906.726","article-title":"Costs and cost-minimisation analysis","volume":"307","author":"Robinson","year":"1993","journal-title":"BMJ"},{"key":"10.1002\/mus.24960-BIB0014|mus24960-cit-0014","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s13311-011-0096-3","article-title":"Immune mediated diseases and immune modulation in the neurocritical care unit","volume":"9","author":"Geldern","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1002\/mus.24960-BIB0015|mus24960-cit-0015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1503\/cmaj.130375","article-title":"Intravenous immunoglobulin as clinical immune-modulating therapy","volume":"187","author":"Gilardin","year":"2015","journal-title":"CMAJ"},{"key":"10.1002\/mus.24960-BIB0016|mus24960-cit-0016","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.nurt.2008.08.011","article-title":"Current and future standards in treatment of myasthenia gravis","volume":"5","author":"Gold","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1002\/mus.24960-BIB0017|mus24960-cit-0017","first-page":"629","article-title":"et al","volume":"5","author":"Kerr","year":"2014","journal-title":"Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe. Front Immunol"},{"key":"10.1002\/mus.24960-BIB0018|mus24960-cit-0018","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.transci.2014.10.002","article-title":"\u201cGo no Go\u201d in plasma fractionation in the world's emerging economies: still a question asked 70 years after the COHN process was developed!","volume":"51","author":"Burnouf","year":"2014","journal-title":"Transfus Apher Sci"}],"container-title":["Muscle & Nerve"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmus.24960","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmus.24960","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/mus.24960\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T23:58:58Z","timestamp":1625443138000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mus.24960"}},"subtitle":["IVIg vs. PLEX in MG"],"short-title":[],"issued":{"date-parts":[[2015,11,26]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"URL":"https:\/\/doi.org\/10.1002\/mus.24960","archive":["Portico"],"relation":{},"ISSN":["0148-639X"],"issn-type":[{"value":"0148-639X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11,26]]}}}